The session will: (1) discuss the history and basic science of PFAS, (2) review recent legislative and regulatory developments concerning PFAS in products including consumer health products, and (3) highlight recent class action litigation and expected future litigation trends. Given the substantial activity in state legislatures around the US that are prohibiting PFAS in certain classes of products, and the recently filed class action lawsuits relating to false advertising on the basis of undisclosed PFAS.
- Understand recent legislative and regulatory PFAS activity.
- Understand PFAS product compliance issues.
- Understand litigation risks relating to PFAS in consumer healthcare products.